EC Number   |
Inhibitors |
Structure |
|---|
    3.5.3.1 | (-)-epicatechin |
(-)-epicatechin leads to a decreased arginase-2 mRNA expression after 24 h of incubation, in contrast a weak basal arginase-1 mRNA expression is not affected |
   |
| 3.5.3.1 | (2S)-2-amino-3-(2-amino-1H-imidazol-5-yl)propanoic acid |
2-aminoimidazole amino acid inhibitor in which the 2-aminoimidazole moiety serves as a guanidine mimetic |
|
| 3.5.3.1 | (2S)-2-amino-3-(2-amino-1H-imidazol-5-yl)propanoic acid |
2-aminoimidazole amino acid inhibitor in which the 2-aminoimidazole moiety serves as a guanidine mimetic, significantly attenuates airways hyperresponsiveness in a murine model of allergic airways inflammation |
|
| 3.5.3.1 | (2S)-2-amino-5-(1H-imidazol-2-ylamino)pentanoic acid |
2-aminoimidazole amino acid inhibitor in which the 2-aminoimidazole moiety serves as a guanidine mimetic |
|
| 3.5.3.1 | (2S,5E)-2-amino-7-oxohept-5-enoic acid |
- |
|
| 3.5.3.1 | (DL)-2-amino-6-borono-2-[1-(3,4-dichlorobenzyl)piperidin-4-yl]-hexanoic acid |
- |
|
| 3.5.3.1 | (R)-2-amino-6-borono-2-[1-(3,4-dichlorobenzyl)piperidin-4-yl]-hexanoic acid |
- |
|
| 3.5.3.1 | (R)-2-amino-6-borono-2-[2-(piperidin-1-yl)ethyl]hexanoic acid |
- |
|
| 3.5.3.1 | (R)-2-amino-6-borono-2[1-(3,4-dichlorobenzyl)piperidin-4-yl]hexanoic acid |
- |
|
| 3.5.3.1 | (S)-(2-boronoethyl)-L-cysteine |
boronic acid-based transition state analogue, classical competitive inhibition at pH 7.5, slow-binding inhibition at pH 9.5 |
|
